Complications and Toxicities Associated with Cancer Therapies in the Intensive Care Unit

Advances in the management of hematologic malignancies and solid tumors have given rise to diverse modalities to treat cancer other than cytotoxic chemotherapy, including targeted therapies, immunotherapies, and cellular therapies. Currently, there are over 175 FDA-approved antineoplastic agents in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Melvin J., Do, Bryan, Bryan, Jeffrey C., Shigle, Terri Lynn, Patel, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121489/
http://dx.doi.org/10.1007/978-3-319-74588-6_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121489/
http://dx.doi.org/10.1007/978-3-319-74588-6_21

Ejemplares similares